A phase II, multicenter, open-label, non-comparative study to evaluate the pharmacokinetics, pharmacodynamics, and tolerability of osilodrostat in children and adolescent patients with Cushing's disease
This important study is investigating a medication called Isturisa for children and teenagers who have Cushing's disease. The main goal is to understand how the body handles this medicine (how it's absorbed, used, and removed), what effects it has, and to check if it's safe and well-tolerated. Researchers will be giving different strengths of Isturisa tablets. They will also be looking to see if the medicine helps keep urine cortisol levels (a marker for Cushing's) normal and how these levels change over time. Your safety and comfort throughout the study are very important to the research team.
Em resumo
Sobre o que é este estudo?
This study is about a medicine called Isturisa, which is already used for adults with Cushing's disease. Now, researchers want to see if it can help children and teenagers who have this condition. Cushing's disease is a health problem where your body makes too much of a hormone called cortisol, which can lead to various health issues.
The study aims to understand how the body processes Isturisa in younger patients – how much medicine gets into the bloodstream, how long it stays there, and how it leaves the body. They also want to see what effects the medicine has on the body and, most importantly, to check if it's safe and if patients can tolerate taking it without too many side effects. This is a "Phase II" study, which means it's an early stage but very important step in testing new treatments.
Finding safe and effective treatments for children and teenagers with Cushing's disease is really important. If this study shows that Isturisa is well-tolerated and works for younger patients, it could potentially offer a new treatment option in the future. The results from this research will help doctors understand the best way to use Isturisa, including the right dose, to help children and teenagers manage their Cushing's disease.
Pontos principais
- This study evaluates Isturisa for children and teenagers with Cushing's disease.
- It aims to understand how the body uses the medicine and check its safety.
- Patients will receive Isturisa tablets and have regular health checks.
- Participation involves clinic visits and taking the study medication.
- Você pode se retirar do estudo a qualquer momento.
Quem pode ser elegível?
This study is looking for children and teenagers who have Cushing's disease. Unlike some studies that have strict age limits, this one says "any to any," meaning they are open to considering patients across a wide age range, as long as they are children or teenagers with Cushing's disease.
Both boys and girls can take part in this study. The most important thing is that you have been diagnosed with Cushing's disease and meet the specific health requirements set out by the research team.
Este estudo pode ser adequado para você?
Responda a estas perguntas rápidas para ver se você pode ser elegível. Este é apenas um guia — a decisão final é da equipe de pesquisa.
- Do you have Cushing's disease?
- Are you a child or teenager?
- Are you able to take tablets by mouth?
- Você consegue comparecer a consultas regulares na clínica?
O que envolve a participação?
If you decide to take part, you would be given Isturisa tablets at different strengths (1mg, 5mg, or 10mg). You and your doctors would decide the best starting dose. You would have regular visits to the clinic where doctors would check your health, take blood and urine samples, and ask you about how you are feeling and any side effects you might be having. These checks help the medical team understand how the medicine is working and ensure you are safe. The total length of time you would be involved in the study would depend on how your body responds to the medicine and what the study doctors think is best for you, but it would involve several months of regular checks and taking the medication.
Riscos e benefícios potenciais
Localizações (3)
- —Não verificadoFrança
- —Não verificadoBélgica
- —Não verificadoItália
Perguntas frequentes
What is Cushing's disease?
Cushing's disease is a condition where your body makes too much of a hormone called cortisol, which can cause various health problems.
What is Isturisa?
Isturisa is a medicine designed to help lower the amount of cortisol your body makes. It's currently used for adults, and this study is testing it for children and teenagers.
Will I get fake medicine (a placebo)?
No, this is an 'open-label' study, which means everyone taking part will receive Isturisa. There won't be a placebo group.
How often will I need to visit the clinic?
You will need to attend regular clinic visits throughout the study. The exact schedule will be explained by the study team.
Posso parar de participar se mudar de ideia?
Yes, you can leave the study at any time, for any reason, without it affecting your medical care.
Como saber mais
Sempre consulte seu médico ou especialista antes de decidir participar de um estudo.
Interessado em participar?
Discussão
Discussão da comunidade
Desenvolvido pelo nosso fórum em community.patient.info. Por favor, seja respeitoso — isto não é um conselho médico.